Shareholders in Diamyd Medical, including the Chairman of the Board, have provided additional subscription commitments in the ongoing rights issue

Chairman of the Board, Anders Essen-Möller, is increasing his commitment by SEK 1 million to a total of SEK 6 million. All members of the management team are subscribing for their pro rata share. In total, the rights issue is covered by subscription commitments and subscription intentions amounting to approximately SEK 47.4 million, corresponding to approximately 22.8 percent of the rights issue.The subscription period for Diamyd Medical’s rights issue runs from April 15 to April 29, 2025. It is also possible to subscribe for units without preferential rights. Allotment of units for